ITF PHARMA GmbH

DED2601V.HRB243415|MünchenGermany

Profit-€2.3M

Balance€18.3M

About

ITF PHARMA GmbH is a company based in München. It is registered in the commercial register of the München local court under HRB 243415.

Source: German Commercial Register (Handelsregister) München Local Court, HRB 243415 (as of 9 October 2026)

Company Structure

Shareholders

Source: German Commercial Register (Handelsregister) München Local Court, HRB 243415 (as of 9 October 2026)

Company History

Management

CPV categories

Pharmaceutical products

Date	Contract	Role	Counterparty	Value
30.9.2026	Bekanntmachung vergebener Aufträge nach §130 a Abs. 8 SGB V und §130 c SGB V zu dem Präparat Duvyzat (Givinostat) Supplier · GWQ ServicePlus AG	Supplier	GWQ ServicePlus AG	—

Financials

Key financial figures over time — ITF PHARMA GmbH
Year	Revenue	Profit	Balance	Employees
2025	Rohergebnis€21.6M²	-€2,345,748	€18,313,060	—
2024	Rohergebnis€16.3M²	-€1,936,796	€14,498,948	—
2023	Rohergebnis€8M²	-€7,800,343	€10,226,860	—
2022	Rohergebnis€8M²	-€5,641,513	€7,029,425	—
2021	Rohergebnis€7.7M²	-€4,342,431	€8,189,224	—
2020	Rohergebnis€6.3M²	-€2,397,385	€10,945,066	—
2019	—	-€5,864,148	€9,810,094	—

² Rohergebnis nach § 276 HGB: Umsatzerlöse abzüglich Materialaufwand bzw. Herstellungskosten. Kleine und mittelgroße Kapitalgesellschaften dürfen diese Posten zusammenfassen; die Umsatzerlöse selbst sind dann nicht veröffentlicht und liegen über dem Rohergebnis.

Source: German Company Register (Unternehmensregister)

Register Files

Current Printout (AD)

Chronological Printout (CD)

List of Shareholders

Articles of Association

Model Protocol

Registration Application

Source: German Commercial Register (Handelsregister) München Local Court, HRB 243415 (as of 9 October 2026)

Contact

Website:teglutik.de

Email:Sign in to view

USt-IdNr.:DE321027705

Annual Financial Statements

Annual Report 2025Published on 30 September 2026

Annual Report 2024Published on 25 August 2025

Annual Report 2023Published on 6 September 2024

Annual Report 2022Published on 29 November 2023

Annual Report 2021Published on 24 August 2022

Annual Report 2020Published on 21 September 2021

Source: German Company Register (Unternehmensregister)

Cost type	Amount	Share
Personnel Costs	€12,111,513	98.8%
Depreciation	€147,842	1.2%
Interest & Similar	€241	0.0%

ITF PHARMA GmbH

About

Company Structure

Company History

Financials

Register Files

Contact

Annual Financial Statements

Cost Distribution (2025)

Trends